Fig. 1 · Structure

Documents & Downloads

Gramine

Cat. No. A10436 CAS 87-52-5
Gramine is a naturally occurring indole alkaloid present in several plant species. Gramine may play a defensive role in these plants, since it is toxic to many organisms. It is used mostly in synthetic organic chemistry as a starting material for tryptophan syntheses.

In Stock

Publications for Gramine

1 publication citing this product

  1. Elizabeth Read, .et al. , Crop and Pasture Science, 2020, 71(4), 389-400

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

In SK-OV-3 and OV-90 cells, 50–100 µM gramine for 24 hours decreased PDK1 protein abundance. This cellular observation does not demonstrate direct PDK1 binding or enzyme inhibition; the authors acknowledge possible indirect stress effects and a lack of target-engagement evidence. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Cellular Effect

Cell Line Activity Value Description Reference
BGC-823 IC50 62.8 μg/mL Cytotoxicity against human BGC823 cells after 72 hrs by MTT assay [PMID: 22647218]
HepG2 IC50 > 100 μg/mL Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay [PMID: 22647218]
NCI-H460 IC50 74.5 μg/mL Cytotoxicity against human NCI-H460 cells after 72 hrs by MTT assay [PMID: 22647218]
SGC-7901 IC50 77.3 μg/mL Cytotoxicity against human SGC7901 cells after 72 hrs by MTT assay [PMID: 22647218]

Gramine Research Summary

This section summarizes 1 in vitro study of Gramine from 1 published reference.

Gramine In Vitro Studies

Gramine reduced 24-hour CCK-8 viability in SK-OV-3 and OV-90 ovarian cancer cells, with reported IC50 values of 78.63 and 117.2 µM. At 50–100 µM, it reduced EdU labeling and increased apoptosis-associated readouts. IOSE80 epithelial-cell viability also declined; its reported IC50 of 393.6 µM exceeds the highest tested concentration of 200 µM and should be interpreted cautiously. [1]

Acute gramine response in ovarian cancer cell lines

Cell-based study · Human SK-OV-3 and OV-90 ovarian cancer cells; IOSE80 ovarian epithelial cells as a viability comparator [1]

A 24-hour concentration-response series reduced CCK-8 viability. At 50 and 100 µM, gramine decreased EdU labeling and PDK1 protein and increased apoptosis-associated readouts. IOSE80 viability also declined; its reported IC50 lies above the tested range. These results do not establish a selective direct molecular target.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
SK-OV-3 CCK-8 viability at 24 hIC50 78.63 µM[1]
OV-90 CCK-8 viability at 24 hIC50 117.2 µM[1]
IOSE80 CCK-8 viability at 24 h; reported estimate exceeds highest tested concentration (200 µM)reported IC50 393.6 µM[1]
EdU-positive cells and Ki67 protein after 24 h at 50 or 100 µMreported result EdU labeling decreased; Ki67 reduction was clearer at 100 µM.[1]
TUNEL positivity and Bax/Bcl-2 and cleaved PARP1/PARP1 ratios at 24 h, 50 or 100 µMreported result TUNEL positivity and apoptosis-associated protein ratios increased versus untreated controls.[1]
PDK1 protein at 24 h, 50 or 100 µMreported result PDK1 protein decreased in both cancer cell lines.[1]

Literature-Reported Treatment Conditions

Treatment concentration
CCK-8: 12.5, 25, 50, 100 and 200 µM; EdU, Ki67, apoptosis and PDK1 readouts: 50 and 100 µM, with 0 µM controls.
Exposure duration
24 h gramine exposure for the adopted endpoints.
Method
Addition to cell culture; comparison with untreated/0 µM controls as labeled in the figures.
Vehicle
DMSO; final concentration <0.1% (v/v) in all cell culture systems, according to the paper.
Reported limits
IC50 fitting model and uncertainty are not specified in the read methods. The reported IOSE80 IC50 exceeds the tested concentration range. Lot-specific applicability to Adooq is not established.
Methods and source locations

Compound reported in the paper: Gramine; Compound label in the paper: HY-N0166, reported purity 99.80% (MedChemExpress)

Compound-level cell-line evidence using another supplier’s material; no verification of an Adooq lot, human efficacy or animal benefit.

Materials and methods: Cell culture and drugs, CCK-8, EdU/TUNEL, western blotting, statistics; Figure 1B,D,E; Figure 2; Figure 4A; Discussion

SK-OV-3 CCK-8 viability at 24 h: CCK-8; 6 replicate wells per group; 3 biological repeats. — Results, first subsection; Figure 1B

OV-90 CCK-8 viability at 24 h: CCK-8; 6 replicate wells per group; 3 biological repeats. — Results, first subsection; Figure 1B

IOSE80 CCK-8 viability at 24 h; reported estimate exceeds highest tested concentration (200 µM): CCK-8. Figure 1B shows the IOSE80 series; the figure caption names only the two cancer lines. Do not interpret the extrapolated estimate as a directly observed 50% endpoint. — Results, first subsection; Figure 1B and Materials and methods, CCK-8

EdU-positive cells and Ki67 protein after 24 h at 50 or 100 µM: EdU microscopy and western blotting; Figure 1 caption reports mean ± SD, three independent experiments. No exact bar heights extracted. — Figure 1D,E and caption; Materials and methods, EdU and western blotting

TUNEL positivity and Bax/Bcl-2 and cleaved PARP1/PARP1 ratios at 24 h, 50 or 100 µM: TUNEL microscopy and western blotting; mean ± SD, three independent experiments as captioned. Responses were not uniformly monotonic across endpoints. — Figure 2A,B and caption; Results, first subsection

PDK1 protein at 24 h, 50 or 100 µM: Western blotting normalized to GAPDH; mean ± SD, three independent experiments as captioned. This is protein abundance, not kinase inhibition or binding. — Figure 4A and caption; Materials and methods, western blotting

Specifications

Manufacturer Adooq Bioscience
CAS Number 87-52-5
Formula C11H14N2
Molecular Weight 174.2
Synonyms 3-(Dimethylaminomethyl)indole
SMILES
CN(C)CC1=CNC2=CC=CC=C21

Storage & Solubility

In Vitro Solubility

Reported Solubility

SolventReported Solubility
DMSO 31 mg/mL (177.91 mM)
Water Insoluble
Ethanol 31 mg/mL (177.91 mM)

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Gramine Research References

  1. [1] Haiyan Wang, Ruiming Zheng, Bujun Wang, et al. PDK1/AKT signaling is involved in the anti-tumor effect of gramine and cisplatin chemoresistance in ovarian cancer cells Experimental and Therapeutic Medicine (2026). PMID: 42719404 DOI: 10.3892/etm.2026.13273 Source material

Publications

1 publication citing this product

  1. Elizabeth Read, .et al. , Crop and Pasture Science, 2020, 71(4), 389-400

Added to your cart

View Cart Checkout
Loading...